SUPER
  1. Home
  2. Stocks
  3. HALEON
  4. News and notes

HALEON · PHARMACEUTICALS

HALEON news and notes Haleon Pakistan Limited

Haleon Pakistan Limited (HALEON) news and notes: the SuperX note, what changed (4 items) and 1 news story. The note is written by SuperX’s AI from its own figures. What changed is listed newest first. Headlines are the publishers’ own words, linked to them.

What SuperX wrote about HALEON

  1. Sector median moved -0.2% today; 5 of 15 scrips rose and 10 fell. Price rose 0.16% on 13 Nov, on low volume.

  2. The annual results cover the period ending 31 Dec. Last year the company filed the same results on 3 Mar.

  3. Price is above the 20-day and 50-day averages, and below the 200-day average. RSI is 60.14, between the middle and high levels.

Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.

What changed for HALEON, newest first

  • 13 Nov 2026Closed 697.10, +0.16%. Volume 14,612, 0.6 times the average of the 30 sessions before it, 25,575.
  • 5 Nov 2026Trend read changed to sideways: above the 50-day average, below the 200-day; roughly flat over 3 months (−6.8%).
  • 29 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 13.05, sales Rs 10.0 bn, down 5.4% on the same quarter a year before.
  • NextAnnual results (to 31 Dec 2026) expected 7 Feb 2027 – 31 Mar 2027, a projection. An estimate from the dates of the last 4 filings.

As of the close of 13 Nov 2026. Closes and notices: PSX. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 4 filings. Not advice.

News about HALEON

From 30 Oct 2026 to 30 Oct 2026. A story is listed here when its headline names the company and names three companies or fewer. Headlines are the publishers’ own words and link to them.

More on HALEON

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .